Literature DB >> 16867529

Application of 1H nuclear magnetic resonance spectroscopy to the analysis of beta-lactam antibiotics and their common degradation products.

S K Branch1, A F Casy, E M Ominde.   

Abstract

The (1)H NMR characteristics of the majority of penicillin and cephalosporin beta-lactam antibiotics in world-wide clinical use are presented. Some of the data are novel and include several high resolution (220, 400 MHz) spectra. The influence of solvent and ionisation state upon spectral parameters is discussed and a scheme of analysis proposed for identifying an unknown beta-lactam sample. Spectral features of common degradation products of benzylpenicillin and other penicillins are provided and the use of (1)H NMR spectroscopy in monitoring the breakdown of penicillin antibiotics described. Other aspects discussed are NMR studies of the stereochemistry, association and protein binding of beta-lactam antibiotics.

Entities:  

Year:  1987        PMID: 16867529     DOI: 10.1016/0731-7085(87)80011-0

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Ampicillin permeation across OmpF, the major outer-membrane channel in Escherichia coli.

Authors:  Ishan Ghai; Harsha Bajaj; Jayesh Arun Bafna; Hussein Ali El Damrany Hussein; Mathias Winterhalter; Richard Wagner
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

2.  The Role of Benzylpenicilloyl Epimers in Specific IgE Recognition.

Authors:  Cristobalina Mayorga; Maria I Montañez; Francisco Najera; Gador Bogas; Tahía D Fernandez; David Rodríguez Gil; Ricardo Palacios; Maria J Torres; Yolanda Vida; Ezequiel Perez-Inestrosa
Journal:  Front Pharmacol       Date:  2021-02-26       Impact factor: 5.810

3.  Conjugation of Penicillin-G with Silver(I) Ions Expands Its Antimicrobial Activity against Gram Negative Bacteria.

Authors:  Ioannis Ketikidis; Christina N Banti; Nikolaos Kourkoumelis; Constantinos G Tsiafoulis; Christina Papachristodoulou; Angelos G Kalampounias; Sotiris K Hadjikakou
Journal:  Antibiotics (Basel)       Date:  2020-01-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.